Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-02-23 to 2024-02-26
Current total value of award: $5636.52
Description: 4563752372!QUILLIVANT XR ORAL SUSP 180ML 5MG/ML